TOCHI AMAECHINA: Open Payments
NPI 1437690997 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 4 payments from 4 companies in 2025. Trend: 2023 $258 · 2024 $294 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $56 |
| ACADIA Pharmaceuticals Inc | 1 | $53 |
| Otsuka America Pharmaceutical, Inc. | 1 | $46 |
| Gilead Sciences, Inc. | 1 | $23 |
Products named: INVEGA SUSTENNA, NUPLAZID, REXULTI.
Industry payments across NJ — which companies pay providers there.
